Financhill
Buy
54

AZTA Quote, Financials, Valuation and Earnings

Last price:
$37.93
Seasonality move :
5.8%
Day range:
$37.24 - $38.55
52-week range:
$23.91 - $55.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.92x
P/B ratio:
1.01x
Volume:
475.9K
Avg. volume:
703.5K
1-year change:
-26.81%
Market cap:
$1.7B
Revenue:
$593.8M
EPS (TTM):
-$1.22

Analysts' Opinion

  • Consensus Rating
    Azenta, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $43.50, Azenta, Inc. has an estimated upside of 14.72% from its current price of $37.92.
  • Price Target Downside
    According to analysts, the lowest downside price target is $39.00 representing -2.85% downside risk from its current price of $37.92.

Fair Value

  • According to the consensus of 5 analysts, Azenta, Inc. has 14.72% upside to fair value with a price target of $43.50 per share.

AZTA vs. S&P 500

  • Over the past 5 trading days, Azenta, Inc. has overperformed the S&P 500 by 11.81% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Azenta, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Azenta, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Azenta, Inc. reported revenues of $159.2M.

Earnings Growth

  • Azenta, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Azenta, Inc. reported earnings per share of $1.11.
Enterprise value:
1.5B
EV / Invested capital:
--
Price / LTM sales:
2.92x
EV / EBIT:
--
EV / Revenue:
2.46x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
38.11x
Price / Operating cash flow:
45.30x
Enterprise value / EBITDA:
31.33x
Gross Profit (TTM):
$270M
Return On Assets:
1.21%
Net Income Margin (TTM):
4.16%
Return On Equity:
1.44%
Return On Invested Capital:
1.39%
Operating Margin:
1.85%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $665.1M $573M $594.1M $150.6M $159.2M
Gross Profit $233.3M $251M $270M $68.5M $72.3M
Operating Income -$85.6M -$25.6M -$10.7M $6.1M $2.9M
EBITDA -$14K $42.3M $46.6M $29.9M $17.4M
Diluted EPS -$0.21 -$3.01 -$1.22 -$0.14 $1.11
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $777.4M $2.5B $1.4B $833M $708.3M
Total Assets $1.8B $3.7B $2.9B $2.1B $2.1B
Current Liabilities $345.1M $230.5M $210.9M $206.1M $237.7M
Total Liabilities $494.2M $352.7M $351.2M $331M $330.7M
Total Equity $1.3B $3.4B $2.5B $1.8B $1.7B
Total Debt $95.1M $49.4M $62.5M $58.2M $52.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $17.5M $49.7M $72.2M $17.6M $2.2M
Cash From Investing $431.4M $224.7M -$90.5M $198M $826K
Cash From Financing -$844.1M -$659.2M -$9.6M -$247.5M $817K
Free Cash Flow -$21.9M $12.4M $38.3M $8.2M -$5.7M
AZTA
Sector
Market Cap
$1.7B
$28.3M
Price % of 52-Week High
68.16%
51.99%
Dividend Yield
0%
0%
Shareholder Yield
-0.04%
-1.59%
1-Year Price Total Return
-26.81%
-17.41%
Beta (5-Year)
1.316
0.495
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $35.95
200-day SMA
Buy
Level $30.94
Bollinger Bands (100)
Buy
Level 29.47 - 34.61
Chaikin Money Flow
Buy
Level 54.2M
20-day SMA
Buy
Level $35.47
Relative Strength Index (RSI14)
Buy
Level 67.77
ADX Line
Buy
Level 24.39
Williams %R
Sell
Level -11.2299
50-day SMA
Buy
Level $33.51
MACD (12, 26)
Buy
Level 0.87
25-day Aroon Oscillator
Buy
Level 20
On Balance Volume
Neutral
Level 81.6M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.8993)
Buy
CA Score (Annual)
Level (1.1837)
Buy
Beneish M-Score (Annual)
Level (-2.6091)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-3.3562)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.

Stock Forecast FAQ

In the current month, AZTA has received 2 Buy ratings 3 Hold ratings, and 0 Sell ratings. The AZTA average analyst price target in the past 3 months is $43.50.

  • Where Will Azenta, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Azenta, Inc. share price will rise to $43.50 per share over the next 12 months.

  • What Do Analysts Say About Azenta, Inc.?

    Analysts are divided on their view about Azenta, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Azenta, Inc. is a Sell and believe this share price will drop from its current level to $39.00.

  • What Is Azenta, Inc.'s Price Target?

    The price target for Azenta, Inc. over the next 1-year time period is forecast to be $43.50 according to 5 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is AZTA A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Azenta, Inc. is a Hold. 3 of 5 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of AZTA?

    You can purchase shares of Azenta, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Azenta, Inc. shares.

  • What Is The Azenta, Inc. Share Price Today?

    Azenta, Inc. was last trading at $37.93 per share. This represents the most recent stock quote for Azenta, Inc.. Yesterday, Azenta, Inc. closed at $37.92 per share.

  • How To Buy Azenta, Inc. Stock Online?

    In order to purchase Azenta, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Why Did Planet Labs Stock Rally So Much?
Why Did Planet Labs Stock Rally So Much?

Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
65
RGC alert for Jan 10

Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.

Sell
50
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock